Back
FibroGen Vs. Fate Therapeutics Industry Stock Comparison
Sell
27
FGEN
FibroGen
Last Price:
1.13
Seasonality Move:
-2.91%
Sell
31
FATE
Fate Therapeutics
Last Price:
4.05
Seasonality Move:
0.14%
Sell
27
FibroGen (FGEN)
is a Sell
Is FibroGen a Buy, Sell or Hold?
- The current FibroGen [FGEN] share price is $1.14. The Score for FGEN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- FGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Fate Therapeutics (FATE)
is a Sell
Is Fate Therapeutics a Buy, Sell or Hold?
- The current Fate Therapeutics [FATE] share price is $4.06. The Score for FATE is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- FATE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FGEN Stock Price Chart
FATE Stock Price Chart
What is Fate Therapeutics's stock price today?
-
The Fate Therapeutics share price today is $4.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing selling pressure, which indicates risk of future bearish movement.
FGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 37.02 | Sell |
| Chaikin Money Flow: | -349515 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.01 - 1.67) | Sell |
| Bollinger Bands (100): | (0.87 - 2.11) | Sell |
FATE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 27.25 | Sell |
| Chaikin Money Flow: | -1914814 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.19 - 6.53) | Sell |
| Bollinger Bands (100): | (3.98 - 7.14) | Sell |
FGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.09 | Buy |
| 20-day SMA: | 1.21 | Sell |
| 50-day SMA: | 1.72 | Sell |
| 200-day SMA: | 1.22 | Sell |
| 8-day EMA: | 1.13 | Buy |
| 20-day EMA: | 1.28 | Sell |
| 50-day EMA: | 1.5 | Sell |
| 200-day EMA: | 3.22 | Sell |
FATE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.03 | Buy |
| 20-day SMA: | 4.96 | Sell |
| 50-day SMA: | 6.35 | Sell |
| 200-day SMA: | 4.06 | Buy |
| 8-day EMA: | 4.19 | Sell |
| 20-day EMA: | 4.86 | Sell |
| 50-day EMA: | 5.58 | Sell |
| 200-day EMA: | 5.69 | Sell |
FibroGen Earnings Growth & FGEN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and an increase next year of $1.84 per share.
Fate Therapeutics Earnings Growth & FATE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.15 per share, and an increase next year of $0.20 per share.
FibroGen Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Fate Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||